|
|
Blood, 1 January 2006, Vol. 107, No. 1, pp. 381-388.
Prepublished online as a Blood First Edition Paper on September 13, 2005; DOI 10.1182/blood-2005-07-2658.
Previous Article | Next Article 
Submitted July 6, 2005
Accepted August 2, 2005
Initial depletion of regulatory T-cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell-therapy
Mariana Mesel-Lemoine, Mustapha Cherai, Sabine Le Gouvello, Maude Guillot, Virginie Leclercq, David Klatzmann, Veronique Thomas-Vaslin, and Francois M Lemoine*
CNRS UMR 7087/UPMC, Hopital de la Pitie Salpetriere, Paris, France
CNRS UMR 7087/UPMC, Hopital de la Pitie Salpetriere, Paris, France; Service de Biotherapies, Hopital de la Pitie Salpetriere, Paris, France
Laboratoire d'Immunologie Biologique, Hopital Henri Mondor, Creteil, France
* Corresponding author; email: francois.lemoine{at}chups.jussieu.fr.
We investigated the causes of the altered functionality of T-cells cultured under conditions designed for cell and gene therapy and the strategies to prevent their defects. We first showed that human T-cells cultured for 6-days with anti-CD3 ± anti-CD28 antibodies and interleukin-2 presented a 50% decrease of their proliferative responses to allogeneic or recall antigens. Similarly, day-6 cultured murine T-cells completely lost their capacity to reject allogeneic skin grafts and to provoke graft versus host disease (GVHD) when infused into irradiated semi-allogeneic mice. Interestingly, injection of higher amount of cultured T-cells restored GVHD induction. Moreover, depletion of CD25+ cells prior to T-cell cultures can prevent these deficiencies both in mice and human. Therefore, we demonstrated that culture conditions used for T-cell therapy preferentially activated and expanded regulatory T-cells (Treg). Thus, we showed that dividing cells sorted from T-cell cultures strongly suppressed the proliferation of autologous T-cells in response to allogeneic stimulation. An increased detection of Foxp3 at mRNA and protein levels in the cultures confirmed the Treg expansion. Overall, we demonstrate that T-cell cultures promote Treg expansion over effector T-cells, leading to deleterious immune functions, and that this imbalance can be prevented by an initial depletion of CD25+ cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Noel, C. Brinster, G. Semana, and D. Bruniquel
Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive
Int. Immunol.,
September 1, 2009;
21(9):
1025 - 1036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. B. Springs, P. W. F. Karmaus, R. B. Crawford, B. L. F. Kaplan, and N. E. Kaminski
Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by {Delta}9-tetrahydrocannabinol
J. Leukoc. Biol.,
December 1, 2008;
84(6):
1574 - 1584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Le Gouvello, S Bastuji-Garin, N Aloulou, H Mansour, M-T Chaumette, F Berrehar, A Seikour, A Charachon, M Karoui, K Leroy, et al.
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Gut,
June 1, 2008;
57(6):
772 - 779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Hombach, D. Kofler, A. Hombach, G. Rappl, and H. Abken
Effective Proliferation of Human Regulatory T Cells Requires a Strong Costimulatory CD28 Signal That Cannot Be Substituted by IL-2
J. Immunol.,
December 1, 2007;
179(11):
7924 - 7931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dang, K. L. Knutson, V. Goodell, C. dela Rosa, L. G. Salazar, D. Higgins, J. Childs, and M. L. Disis
Tumor Antigen-Specific T-Cell Expansion Is Greatly Facilitated by In vivo Priming
Clin. Cancer Res.,
March 15, 2007;
13(6):
1883 - 1891.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|